Positive response from COVID-19 vaccine trial

A Safety News article.

A COVID-19 vaccine based on an inactivated version of coronavirus has been shown to be safe and able to cause an immune response in more than 600 healthy adult patients, The Lancet Infectious Diseases journal has found.

All participants in the early stage trial in China developed antibodies, and no one developed a severe reaction in the month after getting the jab.

To read more, click here.